Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma
CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma Kramer, A., Srinagesh, H., Su, Y., Hamilton, M. P., Levine, K., Migliore, E., Denoble, K., Brown, A. K., Cunanan, K., Agarwal, N., Lohman, C., Mavroukakis, S., Bharadwaj, S., Arai, S., Johnston, L., Lowsky, R., Meyer, E. H., Negrin, R. S., Rezvani, A. R., Shizuru, J., Mikkilineni, L., Hosoya, H., Shiraz, P., Sidana, S., Weng, W., Kennedy, V. E., Smith, M., Dahiya, S., Davis, K. L., Ramakrishna, S., Schultz, L., Tunuguntla, R., Feldman, S. A., Muffly, L., Mackall, C. L., Miklos, D. B., Frank, M. J. ELSEVIER. 2024: 2064-2066View details for DOI 10.1182/blood-2024-198489
View details for Web of Science ID 001412691900040